Clinical trial
Prevention of Osteoporosis in Men With Prostate Cancer on Androgen Deprivation…
NCT00177619 · University of Pittsburgh, Other · Completed
Key facts
| NCT number | NCT00177619 |
|---|---|
| Title | Prevention of Osteoporosis in Men With Prostate Cancer on Androgen Deprivation Therapy (POP Study) |
| Official title | Prevention of Osteoporosis in Men With Prostate Cancer |
| Lead sponsor | University of Pittsburgh, Other |
| Collaborators | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Prostatic Neoplasms |
| Intervention type | Drug |
| Interventions | Alendronate |
| Enrollment | 120 |
| Start date | May 1, 2002 |
| Primary completion | Dec 1, 2005 |
| Completion | Dec 1, 2005 |
| First posted | Sep 15, 2005 |
| Last update posted | Feb 11, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: